MyMD Pharmaceuticals Enhances Governance and Financing Structure

MyMD Pharmaceuticals (MYMD) has provided an update.

MyMD Pharmaceuticals, Inc. has agreed to sell convertible preferred stock and warrants to certain investors, with delayed payment terms now set for May 2024. Additionally, the company has restructured voting rights, allowing preferred shareholders to vote alongside common stockholders and elect a director by the end of June 2024. Following these changes, the company has expanded its board of directors and appointed Mitchell Glass as the new member elected by the preferred shareholders.

See more data about MYMD stock on TipRanks’ Stock Analysis page.